Revolution Medicines, Inc. RVMD Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s quick ratio?
- Revolution Medicines, Inc. (RVMD) reported quick ratio of 6.8× in Q1 2026.
- How has Revolution Medicines, Inc.'s quick ratio changed year-over-year?
- Revolution Medicines, Inc.'s quick ratio decreased by 49.5% year-over-year, from 13.5× to 6.8×.
- What is the long-term trend for Revolution Medicines, Inc.'s quick ratio?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s quick ratio has grown at a -6.2% compound annual growth rate (CAGR), from 52.2× to 40.4×.
- What does quick ratio mean?
- Can the company cover short-term bills without having to sell inventory first?
- How do you interpret quick ratio?
- More conservative than the current ratio. A wide gap between the two flags heavy reliance on inventory to meet near-term obligations.
- How does quick ratio compare across companies?
- Most informative for inventory-heavy businesses; converges with the current ratio for firms that carry little inventory.